171 related articles for article (PubMed ID: 32156620)
1. Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study.
Cai T; Tamanini I; Mattevi D; Verze P; Palmieri A; Malossini G; Mirone V; Novelli A; Tascini C; Johansen TEB
Int J Antimicrob Agents; 2020 Jul; 56(1):105935. PubMed ID: 32156620
[TBL] [Abstract][Full Text] [Related]
2. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
[TBL] [Abstract][Full Text] [Related]
3. Oral fosfomycin for the treatment of chronic bacterial prostatitis.
Karaiskos I; Galani L; Sakka V; Gkoufa A; Sopilidis O; Chalikopoulos D; Alivizatos G; Giamarellou E
J Antimicrob Chemother; 2019 May; 74(5):1430-1437. PubMed ID: 30796442
[TBL] [Abstract][Full Text] [Related]
4. Prolonged course of Fosfomycin-Trometamol for chronic prostatitis: an unknown good option.
Denes E
Scand J Urol; 2021 Aug; 55(4):344-345. PubMed ID: 34060413
[TBL] [Abstract][Full Text] [Related]
5. Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
Cai T; Tiscione D; Gallelli L; Verze P; Palmieri A; Mirone V; Bartoletti R; Malossini G
Arch Ital Urol Androl; 2016 Oct; 88(3):177-182. PubMed ID: 27711089
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.
Los-Arcos I; Pigrau C; Rodríguez-Pardo D; Fernández-Hidalgo N; Andreu A; Larrosa N; Almirante B
Antimicrob Agents Chemother; 2015 Dec; 60(3):1854-8. PubMed ID: 26666924
[TBL] [Abstract][Full Text] [Related]
7. Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline.
Cunha BA; Gran A; Raza M
Int J Antimicrob Agents; 2015 Apr; 45(4):427-9. PubMed ID: 25662814
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
Magri V; Perletti G; Cai T; Stamatiou K; Trinchieri A; Montanari E
Chemotherapy; 2019; 64(1):8-16. PubMed ID: 31112957
[TBL] [Abstract][Full Text] [Related]
9. The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study.
Cai T; Gallelli L; Cione E; Perletti G; Ciarleglio F; Malossini G; De Pretis G; Palmieri A; Mirone V; Bartoletti R; Johansen TEB
World J Urol; 2021 Sep; 39(9):3433-3440. PubMed ID: 33442769
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin for bacterial prostatitis: a review.
Kwan ACF; Beahm NP
Int J Antimicrob Agents; 2020 Oct; 56(4):106106. PubMed ID: 32721595
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial therapy for chronic bacterial prostatitis.
Perletti G; Marras E; Wagenlehner FM; Magri V
Cochrane Database Syst Rev; 2013 Aug; (8):CD009071. PubMed ID: 23934982
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.
Veve MP; Wagner JL; Kenney RM; Grunwald JL; Davis SL
Int J Antimicrob Agents; 2016 Jul; 48(1):56-60. PubMed ID: 27234673
[TBL] [Abstract][Full Text] [Related]
13. Chronic prostatitis caused by extended-spectrum β-lactamase-producing
Almeida F; Santos Silva A; Silva Pinto A; Sarmento A
IDCases; 2019; 15():e00493. PubMed ID: 30766796
[TBL] [Abstract][Full Text] [Related]
14. Prostatic calculi influence the antimicrobial efficacy in men with chronic bacterial prostatitis.
Zhao WP; Li YT; Chen J; Zhang ZG; Jiang H; Xia D; Wang S; Wang P
Asian J Androl; 2012 Sep; 14(5):715-9. PubMed ID: 22796735
[TBL] [Abstract][Full Text] [Related]
15. The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic?
Cai T; Cocci A; Verze P; Rizzo M; Palmieri A; Liguori G; Trombetta C; Adembri C; Carini M; Bartoletti R; Wagenlehner FM; Bonkat G; Mirone V; Bjerklund Johansen TE; Novelli A
J Chemother; 2018 Sep; 30(5):290-295. PubMed ID: 30843774
[TBL] [Abstract][Full Text] [Related]
16. Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.
Pullukcu H; Tasbakan M; Sipahi OR; Yamazhan T; Aydemir S; Ulusoy S
Int J Antimicrob Agents; 2007 Jan; 29(1):62-5. PubMed ID: 17189097
[TBL] [Abstract][Full Text] [Related]
17. Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis.
Stamatiou K; Magri V; Perletti G; Trinchieri A; Lacroix R; Rekleiti N; Moschouris H
Arch Ital Urol Androl; 2019 Jul; 91(2):. PubMed ID: 31266275
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales.
Bouiller K; Zayet S; Lalloz PE; Potron A; Gendrin V; Chirouze C; Klopfenstein T
Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203801
[TBL] [Abstract][Full Text] [Related]
20. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.
Minassian MA; Lewis DA; Chattopadhyay D; Bovill B; Duckworth GJ; Williams JD
Int J Antimicrob Agents; 1998 Apr; 10(1):39-47. PubMed ID: 9624542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
